
America's Most Loved Workplaces® 2026
Karyopharm Therapeutics
Biotechnology · Boston, MA · 300 employees · Led by Richard Paulson, CEO
Certifications
2 across 2 years (2024–2025)
SPARK benchmark
Validated scores publishing when the 2026 research cycle closes
The Story
Why Karyopharm Therapeutics is Most Loved
Karyopharm Therapeutics is a global leader in oncology innovation; its pioneering SINE (Selective Inhibition of Nuclear Export) technology targets cancer cells in a novel way for blood cancers and solid tumors. Headquartered in Newton, MA, with its first FDA-approved product now available across the U.S., Europe, and Asia and a pipeline extending into rare diseases.
- Positive Vision
- A bold path to defeat cancer, with every employee playing a role in delivering life-changing therapies.
- Values
- ICARE: Innovation, Courage, Alignment, Resilience, Energy, embedded in talent management and the ICARE Awards.
- CEO Strengths
- Richard Paulson champions innovation and resiliency, sets clear goals, and genuinely cares about people while scaling a commercial-stage biotech.
- Respect
- Open forums and programs promoting transparency, integrity, and diversity of thought; ERGs and Inclusion & Wellness.
- Loved Culture
- A cross-functional, silo-breaking environment where every contribution is valued.
- Benefits
- Competitive comp, an industry-leading flexible/remote model with monthly Core-Weeks, KaryoFlex Fridays, a $1,200 wellness stipend, Headspace, and HRA/HSA medical plans. Commitments: half-day Fridays year-round, pet insurance, volunteer time off, wellness & development stipends, tuition reimbursement, 401(k), mentorship programs.